SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

PKP Peak Processing Limited

Healthcare · Drug Manufacturers - Specialty & Generic · website
$0.02
52wk 0.01 – 0.02
Overall
45.9
Value
97.6
Growth
81.3
Health
0.0
Quality
0.0
Momentum
36.7
Dividend
—
Price
About Peak Processing Limited

Peak Processing Limited, together with its subsidiaries, provides cannabis products and services in Canada and the United States. It provides cannabis products, including beverages, hydrocarbon extracts, oils, vapes, topicals, powders, infused flowers, and edibles. The company also offers market insights and analysis, product development, manufacturing, commercialization, distribution, and product rework services. It sells its products through retail stores. The company was formerly known as Althea Group Holdings Limited and change its name to Peak Processing Limited in November 2025. Peak Processing Limited was founded in 2016 and is based in Melbourne, Australia.

Price analytics

Returns

1 day -3.0%
1 week 0.0%
1 month 14.3%
3 months -11.1%
6 months 0.0%
1 year -15.8%
3 years -48.4%

Risk

Volatility (1y ann.) 71.6%
Beta vs ASX 200 0.77
Sharpe (1y) 0.06
VaR 95% (1-day) -6.3%
Max drawdown (1y) -33.3%
Off 1-year high -23.8%

Technicals

RSI(14) 50
vs 50DMA 4.5%
vs 200DMA -4.8%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 97.6
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
—
Price / Sales
94
Growth 81.3
Revenue growth (1y)
81
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 0.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
0
Debt / Equity
—
Quality (Profitability & Cash Flow) 0.0
Return on equity
—
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 36.7
6-month return vs ASX 200
26
Price vs 200-day average
34
Price vs 50-day average
72
Position in 52-week range
20

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$21.43M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
1.33
EV / EBITDA
—
Price / Book
—
ROE
—
Operating margin
-26.2%
Net margin
-60.0%
Total cash
—
Total debt
—
Current ratio
0.93
Debt / Equity
—
Free cash flow
$-6.32M
Avg volume
2.10M
Latest annual results (FY ending 30 Jun 2024)
  • Revenue$29.40M
  • Gross profit$17.46M
  • Operating income-$11.70M
  • Net income-$32.06M
  • Diluted EPS-0.09
  • Free cash flow-$4.83M
  • Net debt$6.21M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4